Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents - Wikidata - wikimedia - TriplyDB

Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents

Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents

http://www.wikidata.org/entity/Q34831800

about

Population pharmacokinetic modeling of risperidone and 9-hydroxyrisperidone to estimate CYP2D6 subpopulations in children and adolescents.Correlates of weight gain during long-term risperidone treatment in children and adolescents Iron deficiency in pediatric patients in long-term risperidone treatment Pharmacogenetics of clinical response to risperidone.Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review.Safety and pharmacokinetics of atypical antipsychotics in children and adolescents.Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic.Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings.Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children.Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9-Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders.

P2860

Q36233555-05A08C2E-2D1B-48B5-B4E5-74885B2BF305 Q36373562-4240C63E-17EB-4DC2-B5CE-A021084C770E Q36720726-D422A90B-1D20-4EF5-BDF7-2CF29E44118C Q38074712-1DDD1659-5E38-4163-ABAF-AF25BFCDDA5B Q38090490-F1B9A0D7-CA73-408E-98DD-B3E06FC116D7 Q38099224-4A27E749-58E1-4FDE-8317-6AD9656051B5 Q38154915-90B8F88A-4A84-47E1-BE8F-F0EE1B7A95D4 Q40267262-416D4F37-3D29-41FA-B6A2-2272D4C2D7C6 Q47161187-0DCAFA02-DEAD-4362-AB11-7BBC6A02A9C3 Q47898060-9B07DA01-3963-4E95-918D-E67C9B2A2C09

P2860

Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents

http://www.wikidata.org/entity/Q34831800

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Predictors of risperidone and ...... on in children and adolescents

@ast

Predictors of risperidone and ...... on in children and adolescents

@en

Predictors of risperidone and ...... on in children and adolescents

@nl

type

label

Predictors of risperidone and ...... on in children and adolescents

@ast

Predictors of risperidone and ...... on in children and adolescents

@en

Predictors of risperidone and ...... on in children and adolescents

@nl

prefLabel

Predictors of risperidone and ...... on in children and adolescents

@ast

Predictors of risperidone and ...... on in children and adolescents

@en

Predictors of risperidone and ...... on in children and adolescents

@nl

P1433

Q34831800-D2C38827-8494-4721-9F9D-8AD5BF524735

P1476

Q34831800-62120002-1D26-4B84-9E46-50E8D5F67595

P2093

Q34831800-828EB276-3DDF-4ECB-9F68-D70885226E38

Q34831800-D28C49F7-7B73-49C6-B529-0B487C5365B4

P2860

Q34831800-0CECC449-CA0B-4262-A75E-53295807C2D4

Q34831800-0DB3171B-035F-4E21-BA81-7DABE3D97597

Q34831800-2553F7D5-6F9E-4C88-AAB0-28493E732488

Q34831800-3E1C87F7-3DAA-4E27-B561-540EE92BAEE9

Q34831800-40588EFB-D0C7-4552-8304-13AD5B5207AB

Q34831800-45A883DF-B30D-4725-A7A9-34E873D17E18

Q34831800-4F0AA0C5-EF5F-4D3B-8164-891B2593FA0E

Q34831800-5929BC79-4B6C-42C9-8D90-D844A860201B

Q34831800-59557455-A580-4204-9F5D-89AA8DCF3B2F

Q34831800-650F40AF-0A88-4D28-BAA0-51F4E6046C28

P304

Q34831800-FF3EB388-5830-49FF-B9E7-D0E657A9FE7E

P31

Q34831800-0613CA0E-2DE6-4B82-BDBD-86AE46F041BE

P356

Q34831800-8DE32D55-5148-4A20-8732-BEE7185C86AD

P433

Q34831800-72F6272F-039F-45A4-9F7E-1DAA3649DC01

P478

Q34831800-359EF078-961B-4F3F-91FB-59FABB14FEB9

P577

Q34831800-2C9611B1-3A04-4A98-B836-5F70B6AD230F

P5875

Q34831800-7634DEDC-AD32-4139-9D30-13BB3C70935B

P698

Q34831800-0F52CA05-A950-4D12-8DAA-F758AD71D725

P921

Q34831800-822A1256-20B2-4977-970E-71285B56B261

P932

Q34831800-18FC547E-592E-470C-B23A-504AF404367D

P356

P1433

Journal of Child and Adolescent Psychopharmacology

P1476

Predictors of risperidone and ...... on in children and adolescents

@en

P2093

Chadi Albert Calarge

http://www.w3.org/2001/XMLSchema#string

Del D Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Variations in pattern of pubertal changes in girls

Variations in the pattern of pubertal changes in boys

Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers

A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys.

CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.

Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.

Ontogeny of dextromethorphan O- and N-demethylation in the first year of life.

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

P304

163-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/CAP.2010.0038

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51044852

http://www.w3.org/2001/XMLSchema#string

P698

21486167

http://www.w3.org/2001/XMLSchema#string

P921

P932

3080754

http://www.w3.org/2001/XMLSchema#string